关注
Osama Badary
Osama Badary
Professor of Clinical Pharmacy- Ain Shams University
在 must.edu.eg 的电子邮件经过验证
标题
引用次数
引用次数
年份
Thymoquinone is a potent superoxide anion scavenger
OA Badary, RA Taha, AM Gamal El-Din, MH Abdel-Wahab
Drug and chemical toxicology 26 (2), 87-98, 2003
6242003
The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats
OA Badary, AB Abdel-Naim, MH Abdel-Wahab, FMA Hamada
Toxicology 143 (3), 219-226, 2000
4182000
Thymoquinone protects against carbon tetrachloride hetatotoxicity in mice via an antioxidant mechanism
MN Nagi, K Alam, OA Badary, OA Al‐Shabanah, HA Al‐Sawaf, ...
IUBMB Life 47 (1), 153-159, 1999
3611999
Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity
OA Badary, MN Nagi, OA Al-Shabanah, HA Al-Sawaf, MO Al-Sohaibani, ...
Canadian journal of physiology and pharmacology 75 (12), 1356-1361, 1997
2921997
Naringenin attenuates cisplatin nephrotoxicity in rats
OA Badary, S Abdel-Maksoud, WA Ahmed, GH Owieda
Life sciences 76 (18), 2125-2135, 2005
2822005
A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2
AM Mansour, J Drevs, N Esser, FM Hamada, OA Badary, C Unger, ...
Cancer research 63 (14), 4062-4066, 2003
2712003
Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice
OA Badary
Journal of ethnopharmacology 67 (2), 135-142, 1999
2561999
Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis.
OA Badary, GED AM
Cancer detection and prevention 25 (4), 362-368, 2001
2512001
Inhibition of benzo (a) pyrene-induced forestomach carcinogenesis in mice by thymoquinone
OA Badary, OA Ai-shabanah, MN Nagi, AC AI-Rikabi, MMA Elmazar
European Journal of Cancer Prevention 8 (5), 435-440, 1999
2391999
Acute and subchronic toxicity of thymoquinone in mice
OA Badary, OA Al‐Shabanah, MN Nagi, AM Al‐Bekairi, M Elmazar
Drug Development Research 44 (2‐3), 56-61, 1998
2211998
Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity.
OA Al-Shabanah, OA Badary, MN Nagi, NM Al-Gharably, AC Al-Rikabi, ...
Journal of experimental & clinical cancer research: CR 17 (2), 193-198, 1998
2171998
Cross-sectional study on awareness and knowledge of COVID-19 among senior pharmacy students
MS Hamza, OA Badary, MM Elmazar
Journal of community health 46, 139-146, 2021
1422021
Frequent co-occurrence of the TATA box mutation associated with Gilbert’s syndrome (UGT1A1* 28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6* 2 …
C Köhle, B Möhrle, PA Münzel, M Schwab, D Wernet, OA Badary, ...
Biochemical pharmacology 65 (9), 1521-1527, 2003
1252003
Anticlastogenic activity of thymoquinone against benzo (a) pyrene in mice
OA Badary, MF Abd-Ellah, MA El-Mahdy, SA Salama, FM Hamada
Food and Chemical Toxicology 45 (1), 88-92, 2007
1012007
The protective action of thymol against carbon tetrachloride hepatotoxicity in mice
K Alam, MN Nagi, OA Badary, OA Al-Shabanah, AC Al-Rikabi, ...
Pharmacological research 40 (2), 159-163, 1999
911999
Ameliorative effects of resveratrol on liver injury in streptozotocin‐induced diabetic rats
N Hamadi, A Mansour, MH Hassan, F Khalifi‐Touhami, O Badary
Journal of biochemical and molecular toxicology 26 (10), 384-392, 2012
872012
Thymoquinone alleviates the experimentally induced Alzheimer’s disease inflammation by modulation of TLRs signaling
YS Abulfadl, NN El-Maraghy, AAE Ahmed, S Nofal, Y Abdel-Mottaleb, ...
Human & experimental toxicology 37 (10), 1092-1104, 2018
852018
In vitro and in vivo effects of ferulic acid on gastrointestinal motility: inhibition of cisplatin-induced delay in gastric emptying in rats
OA Badary, AS Awad, MA Sherief, FMA Hamada
World Journal of Gastroenterology: WJG 12 (33), 5363, 2006
832006
Protective effect of thymoquinone against carbon tetrachloride-induced hepatotoxicity in mice
NM Al-Gharably, OA Badary, MN Nagi, OA Al-Shabanah, HA Al-Sawaf, ...
801997
Reducing prescribing errors in the paediatric intensive care unit: an experience from Egypt
HZ Alagha, OA Badary, HM Ibrahim, NA Sabri
Acta Paediatrica 100 (10), e169-e174, 2011
792011
系统目前无法执行此操作,请稍后再试。
文章 1–20